中国药房2016，Vol.27Issue(15)：2073-2075,2076,4.DOI:10.6039/j.issn.1001-0408.2016.15.20
中药联合肝动脉化疗栓塞术治疗原发性肝癌系统评价的再评价Δ
Reevaluation of the Systematic Review of the Traditional Chinese Medicine Combined with Transarterial Che-moembolization in the Treatment of Primary Liver Cancer
摘要
Abstract
OBJECTIVE:To evaluate the methodological bias of systematic review and the reliability of counclusions of tradi-tional Chinese medicine (TCM) combined with transarterial chemoembolization in the treatment of primary liver cancer,and pro-vide evidence-based reference. METHODS:Retrieved from Cochrane Library,PubMed,Guideline,CBM,CJFD and Wanfang Da-tabase,high quality systematic review about TCM combined with transarterial chemoembolization in the treatment of primary liver cancer was collected for reevaluation. RESULTS:Totally 12 systematic review were involved. Results showed TCM combined with transarterial chemoembolization can improve tumor’s objective response,prolong the survival time of patients,improve life quali-ty,reduce postoperative adverse reactions with no serious adverse reactions reported related to TCM in the treatment of primary liv-er cancer. CONCLUSIONS:The clinical efficacy of TCM combined with transarterial chemoembolization is superior to transarterial chemoembolization alone in the treatment of primary liver cancer,with better safety.关键词
经肝动脉化疗栓塞术/原发性肝癌/中药/系统评价Key words
Transarterial chemoembolization/Primary liver cancer/Traditional Chinese medicine/Systematic review分类
医药卫生引用本文复制引用
顾露,吴冬梅,谢坪..中药联合肝动脉化疗栓塞术治疗原发性肝癌系统评价的再评价Δ[J].中国药房,2016,27(15):2073-2075,2076,4.基金项目
四川省卫生厅科研课题 （）
